Mylan Laboratories Limited, a subsidiary of global pharmaceutical company Mylan, expanded its health care offerings for women on Nov. 20 by acquiring Famy Care Limited's female health care businesses known as Jai Pharma. Read More »

Eli Lilly and Co.'s drug Portrazza was approved by the Food and Drug Administration (FDA) Nov. 24 as a combination treatment for advanced squamous non-small cell lung cancer (NSCLC). Read More »

Biotechnology company Pieris Pharmaceuticals announced Monday that it received a milestone payment of an undisclosed amount from Sanofi for the continuous advancement of the tetraspecific Anticalin-based program for infectious disease. Read More »

CVS announced Monday that Repatha will be the only PCSK9 inhibitor added to its market.  Read More »

Recent doctor of pharmacy graduates can now learn how to become independent community pharmacy owners with the University of North Carolina at Chapel Hill (UNC)-Eshelman School of Pharmacy's recently launched pharmacy residency program. Read More »

The Children’s Hospital of Philadelphia (CHOP) is working with health care provider Aetna to improve the quality of health care and reduce costs. Read More »

Thomas Reuters recently named research-driven pharmaceutical company Boehringer Ingelheim a leader in innovation. Read More »

AstraZeneca entered into three partnerships Nov. 20 aimed at expanding technology capabilities at its new research facility on the Cambridge Biomedical Campus in England. Read More »

Missouri residents will now have access to more MinuteClinics as new locations were recently opened in Springfield. Read More »

National Community Pharmacist Association (NCPA) President Bradley Arthur provided testimony Nov. 17 on the dominating power that large pharmacy benefit management (PBM) corporations have on the pharmaceutical marketplace. Read More »

Cigna announced Monday it has expanded its health offerings in Missouri by making its Medicare Advantage health plan available to Kansas City residents. Read More »

CVS Health introduced various digital tools Nov. 18 in order to make health management easier and more efficient for its customers. Read More »

More than 200 members of the American Society of Health-System Pharmacists (ASHP) recently approved three professional policies at the organization's inaugural virtual House of Delegates. Read More »

AstraZeneca Pharmaceutical's Tagrisso was approved by the Food and Drug Administration (FDA) Nov. 13 as a treatment for advanced non-small cell lung cancer (NSCLC). Read More »

The National Association of Chain Drug Stores (NACDS) joined the Centers for Disease Control and Prevention (CDC) in commemorating the recent Get Smart about Antibiotics Week. Read More »

The Phoenix Business Journal honored Avella Specialty Pharmacy with two Arizona Corporate Excellence (ACE) Awards Nov. 12. Read More »

The Food and Drug Administration (FDA) accepted Accu-Break Pharmaceutical's New Drug Application (NDA) for warfarin potassium Thursday. Read More »

Janssen Research & Development submitted an application to the Food and Drug Administration (FDA) Friday for the approval of Invokamet as an adjunctive treatment in adults with type 2 diabetes. Read More »

The Food and Drug Administration (FDA) approved the first nasal spray version of naloxone Wednesday as an emergency life-saving treatment for opioid overdose. Read More »

Biopharmaceutical company AstraZeneca recently agreed to sell the U.S. rights to its Crohn's disease drug Entocort to Perrigo Company for $380 million. Read More »